Toxicity of upfront (131)I-metaiodobenzylguanidine ((131)I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis

PURPOSE: In the treatment of patients with high-risk neuroblastoma, different doses of (131)I-metaiodobenzylguanidine ((131)I-MIBG) are administered at different time points during treatment. Toxicity, mainly haematological (thrombocytopenia), from (131)I-MIBG therapy is known to occur in extensivel...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bleeker, Gitta, Schoot, Reineke A., Caron, Huib N., de Kraker, Jan, Hoefnagel, Cees A., van Eck, Berthe L., Tytgat, Godelieve A.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2013
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3788185/
https://ncbi.nlm.nih.gov/pubmed/23921531
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-013-2510-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars